Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry
Young Suk Park, Jiafu Ji, John Raymond Zalcberg, Mostafa El-Serafi, Antonio Buzaid, Marwan Ghosn
Asia-Pacific Journal of Clinical Oncology | WILEY | Published : 2015
This study was funded by Sanofi Aventis. Sincere thanks to all the participating investigators, clinical trial staff and others who supported the conduct of this study.